HJV hemochromatosis, iron overload, and hypogonadism in a Brazilian man: treatment with phlebotomy and deferasirox

Acta Haematol. 2010;124(4):204-5. doi: 10.1159/000321493. Epub 2010 Nov 12.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoates / therapeutic use*
  • Brazil
  • Cation Transport Proteins / genetics
  • Combined Modality Therapy
  • Deferasirox
  • Exons / genetics
  • Gene Amplification
  • Hemochromatosis / complications
  • Hemochromatosis / congenital
  • Hemochromatosis / genetics
  • Hemochromatosis / physiopathology
  • Hemochromatosis / therapy
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I / genetics
  • Humans
  • Hypogonadism / complications*
  • Hypogonadism / physiopathology
  • Iron Chelating Agents / therapeutic use*
  • Iron Overload / complications
  • Iron Overload / physiopathology
  • Iron Overload / therapy*
  • Magnetic Resonance Imaging
  • Male
  • Membrane Proteins / genetics
  • Phlebotomy / methods*
  • Polymorphism, Single Nucleotide
  • Receptors, Transferrin / genetics
  • Stroke Volume
  • Triazoles / therapeutic use*
  • Young Adult

Substances

  • Benzoates
  • Cation Transport Proteins
  • HFE protein, human
  • Hemochromatosis Protein
  • Histocompatibility Antigens Class I
  • Iron Chelating Agents
  • Membrane Proteins
  • Receptors, Transferrin
  • TFR2 protein, human
  • Triazoles
  • metal transporting protein 1
  • Deferasirox

Supplementary concepts

  • Hemochromatosis, type 2